Paracetamol: new vistas of an old drug.
A. Bertolini,
A. Ferrari,
A. Ottani,
S. Guerzoni,
R. Tacchi,
S. Leone
|
9 |
2006 |
9
2006
|
A review of the pharmacological and clinical profile of mirtazapine.
S. Anttila,
E. Leinonen
|
8 |
2006 |
8
2006
|
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
M. Rogawski,
G. Wenk
|
8 |
2006 |
8
2006
|
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
10 auth.
D. Piomelli,
G. Tarzia,
A. Duranti,
A. Tontini,
M. Mor,
T. Compton,
...
O. Dasse,
E. P. Monaghan,
J. Parrott,
D. Putman
|
8 |
2006 |
8
2006
|
Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury.
H. Yoshida,
H. Yanai,
Y. Namiki,
Kayoko Fukatsu-Sasaki,
N. Furutani,
N. Tada
|
8 |
2006 |
8
2006
|
Lacosamide: a review of preclinical properties.
B. Beyreuther,
J. Freitag,
C. Heers,
N. Krebsfänger,
U. Scharfenecker,
T. Stöhr
|
8 |
2007 |
8
2007
|
Valproate: past, present, and future.
Cecilie U. Johannessen,
S. Johannessen
|
8 |
2006 |
8
2006
|
Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease.
S. Lilienfeld
|
8 |
2006 |
8
2006
|
Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.
L. Dwoskin,
A. Rauhut,
K. King-Pospisil,
M. Bardo
|
8 |
2006 |
8
2006
|
Piracetam: a review of pharmacological properties and clinical uses.
B. Winblad
|
8 |
2006 |
8
2006
|
Paroxetine: a review.
M. Bourin,
P. Chue,
Y. Guillon
|
7 |
2006 |
7
2006
|
SCH 23390: the first selective dopamine D1-like receptor antagonist.
James A. Bourne
|
7 |
2006 |
7
2006
|
Moclobemide: therapeutic use and clinical studies.
U. Bonnet
|
7 |
2003 |
7
2003
|
